HEMANEXT INC.

Profile

Company Names

HEMANEXT INC.
NEW HEALTH SCIENCES, INC.

Addresses

99 HAYDEN AVENUE, BUILDING B, SUITE 620, LEXINGTON, MA 02421

99 HAYDEN AVENUE, BUILDING B, SUITE 620, LEXINGTON, MA 02421

99 HAYDEN AVENUE, BUILDING B, SUITE 62, LEXINGTON, MA 02421

6903 ROCKLEDGE DRIVE, SUITE 230, BETHESDA, MD 20817

Phone Numbers

(781) 301-7463
(781) 301-7474
(617) 945-5079
(301) 493-5550

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$134,600,248.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2025-07-18 
$19,978,442.00 
$24,000,000.00 
$4,021,558.00 
Equity 
8
2024-11-07 
$21,714,277.00 
$21,714,277.00 
$0.00 
Equity 
7
2023-12-18 
$5,005,000.00 
$10,000,000.00 
$4,995,000.00 
Equity 
6
2023-06-21 
$11,285,000.00 
$11,285,000.00 
$0.00 
Equity 
5
2022-07-19 
$13,248,996.00 
$15,000,000.00 
$1,751,004.00 
Equity 
4
2019-08-08 
$39,636,597.00 
$59,475,000.00 
$19,838,403.00 
Equity 
3
2018-02-02 
$8,750,000.00 
$16,000,000.00 
$7,250,000.00 
Debt 
2
2017-10-24 
$2,700,000.00 
$5,000,000.00 
$2,300,000.00 
Equity 
1
2011-07-22 
$12,281,936.00 
$17,600,000.00 
$5,318,064.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EDUARDO 
 
AVAYA 
DIRECTOR
EDUARDO 
 
AVAYU 
DIRECTOR
JOSEPH 
B. 
BARRETT 
EXECUTIVE OFFICER
MICHAEL 
 
BAVONESE 
EXECUTIVE OFFICER
JILL 
 
BUCKLEY 
EXECUTIVE OFFICER
MARTIN 
A. 
CANNON 
EXECUTIVE OFFICER, DIRECTOR
GUY 
 
COGAN 
DIRECTOR
GEOFFREY 
 
CROUSE 
DIRECTOR
LAURA 
 
DANIELS 
EXECUTIVE OFFICER
KIMBERLY 
 
DORSCH 
EXECUTIVE OFFICER
ANDREW 
 
DUNHAM 
EXECUTIVE OFFICER, DIRECTOR
STEPHEN 
A. 
ECKERT 
DIRECTOR
STEVE 
 
ECKERT 
DIRECTOR
JOSEPH 
 
GROGAN 
DIRECTOR
ROBERT 
 
HAIME 
EXECUTIVE OFFICER
DAAN 
 
KOK 
EXECUTIVE OFFICER
ISMAIL 
 
KOLA 
DIRECTOR
LYNN 
 
MALLETT 
EXECUTIVE OFFICER
ALEX 
 
MARICHAL 
EXECUTIVE OFFICER
PAUL 
M. 
NESS 
DIRECTOR
ERIC 
 
NEWMAN 
EXECUTIVE OFFICER
FLORIDA BUSINESS BANCGROUP INC   |  30 SECOND SOFTWARE INC   |  30 SECOND SOFTWARE, INC.   |  HUNTRISE CAPITAL PARTNERS LLC   |  HUNTRISE GLOBAL PARTNERS LTD   |  NEW HEALTH SCIENCES, INC.   |  HEMANEXT INC.   |  AMERICAN VENTURES LLC, SERIES V TZUP I   |  AMERICAN VENTURES LLC, SERIES VI TZUP II   |  AMERICAN VENTURES LLC, SERIES III SRM   |  AMERICAN VENTURES LLC, SERIES XVI AGH   |  AMERICAN VENTURES LLC, SERIES XXI DRONE   |  AMERICAN VENTURES LLC, SERIES I TRON   |  AMERICAN VENTURES LLC, SERIES X SHOT   |  AMERICAN VENTURES LLC, SERIES XII SHOT   |  AMERICAN VENTURES LLC, SERIES II DOGE   |  AMERICAN VENTURES LLC, SERIES VII USDAE   |  AMERICAN VENTURES LLC, SERIES XIX SKBL   |  AMERICAN VENTURES LLC, SERIES XXIII HEMI   |  AMERICAN VENTURES LLC, SERIES XI JEWEL DIGITAL   |  AMERICAN VENTURES LLC, SERIES XIV JFB   |  AMERICAN VENTURES LLC, SERIES XXVI PRE   |  AMERICAN VENTURES LLC, SERIES XXXI QLE   |  AMERICAN VENTURES LLC, SERIES XXXII SKBL II   |  ANETAC, INC.   |  AMERICAN VENTURES LLC, SERIES XXXIX MMA   |  AMERICAN VENTURES LLC, SERIES XXXIV ENERGY I   |  AMERICAN VENTURES LLC, SERIES XXXVI SIM SPONSOR I   |  AMERICAN VENTURES LLC, SERIES IX QUANTUM LEAP   |  AMERICAN VENTURES LLC, SERIES XX TRACX LOGIS   |  AMERICAN VENTURES LLC, SERIES XXX SUPERCRITICAL   |  AMERICAN VENTURES LLC, SERIES VIII FABRIC   |  AMERICAN VENTURES LLC, SERIES IV POWER US   |  AMERICAN VENTURES LLC, SERIES XXV JFB II   |  AMERICAN VENTURES LLC, SERIES XXIV XWELL   |  AMERICAN VENTURES LLC, SERIES XIII SKBL III   |  AMERICAN VENTURES LLC, SERIES XLI KAZ   |  AMERICAN VENTURES LLC, SERIES XLVI DTCX   |  AMERICAN VENTURES LLC, SERIES XLII SPONSOR 1   |  AMERICAN VENTURES LLC, SERIES XLIV DBC   |  AMERICAN VENTURES LLC, SERIES XLVII QUALITY ONE   |  AMERICAN VENTURES LLC, SERIES XVII DTCXS   |  AMERICAN VENTURES LLC, SERIES XXXV NAS   |  AMERICAN VENTURES LLC, SERIES XLVIII REMAG   |  AMERICAN VENTURES LLC, SERIES LI HERITAGE   |  AMERICAN VENTURES QP OPPORTUNITY FUND LLC, SERIES III FIGURE AI   |  AMERICAN VENTURES QP OPPORTUNITY FUND LLC, SERIES IV SPACEX   |  AMERICAN VENTURES LLC, SERIES XXXVIII TRACX LOGIS ADVISORY   |  AMERICAN VENTURES OPPORTUNITY FUND LLC, SERIES II VAST ADVISORY
ERIC 
J. 
NEWMAN 
EXECUTIVE OFFICER
WILLIAM 
PATRICK 
O-NEILL 
DIRECTOR
LAUREL 
 
OMERT 
EXECUTIVE OFFICER
PHILIP 
M. 
PEAD 
DIRECTOR
RICHARD 
 
PERLE 
DIRECTOR
DAVID 
 
TESTA 
DIRECTOR
MICHAEL 
DAVID 
TESTA 
DIRECTOR
PETER 
 
TESTA 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-18 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-11-07 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-18 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-21 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-02-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-02-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
OCTAVIAN AG
NONE
NONE
NONE
SONENSHINE + COMPANY LLC